Related Experiment Video
Updated: May 11, 2026

05:34
Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
Published on: June 6, 2025
Automatic knowledge extraction from chemical structures: the case of mutagenicity prediction
T Ferrari1, D Cattaneo, G Gini
1Department of Electronics and Information, Politecnico di Milano, Milan, Italy.
SAR and QSAR in Environmental Research
|May 29, 2013
Summary
This study introduces a new structure-activity relationship (SAR) method to identify molecular fragments linked to biological activity. The approach enhances prediction reliability and user control, successfully applied to mutagenicity.
Area of Science:
- Computational chemistry and cheminformatics
- Toxicology and drug discovery
Background:
- Structure-activity relationship (SAR) studies are crucial for understanding molecular interactions.
- Identifying structural alerts is key for predicting biological activity and potential toxicity.
- Existing methods may lack transparency or user control in fragment mining.
Purpose of the Study:
- To develop a novel SAR approach for mining molecular fragments associated with biological activity.
- To create a system that aligns with human reasoning for improved reliability and user customization.
- To validate the approach using the mutagenicity endpoint.
Main Methods:
- Development of a new SAR methodology focused on fragment identification.
- Integration of human-interpretable reasoning into the prediction process.
- Application and testing of the approach on mutagenicity data.
Main Results:
- The proposed SAR approach demonstrated significant predictive capabilities for mutagenicity.
- The method successfully identified known structural alerts from existing literature.
- New evidence and previously unrecognized molecular fragments were uncovered.
Conclusions:
- The novel SAR approach offers a reliable and user-controllable method for identifying biologically active molecular fragments.
- This technique aids in the discovery of toxicological and pharmacological knowledge.
- The approach holds promise for applications in drug discovery and safety assessment.
Related Concept Videos
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Predicting Molecular Geometry
VSEPR Theory for Determination of Electron Pair Geometries
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
